Introduction
Opioid pharmacotherapy is one of the main treatment options for dependence on opioid drugs, such as heroin and morphine. Treatment involves replacing the opioid drug of dependence with a legally obtained, longer-lasting opioid. In Australia, clients attend dosing point sites (for example, pharmacies) regularly to take the dose of their prescribed medication under the supervision of a pharmacist or other health professional.
Clients who receive pharmacotherapy treatment can be captured in various data sources. The two national sources presented in this report are:
- Alcohol and Other Drug Treatment Services National Minimum Data Set (AODTS NMDS)
- National Opioid Pharmacotherapy Statistics Annual Data (NOPSAD) Collection.
Due to the specifications of these collections, it is not possible to directly compare or identify people who received pharmacotherapy treatment via dosing point site as well as treatment from a publicly funded alcohol and other drug (AOD) service (see notes for more details). However, exploring this information in parallel can provide a more detailed picture about pharmacotherapy treatment in Australia.